Cargando…
Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization
Tuberculosis (TB) is a global public health problem, which is caused by Mycobacterium tuberculosis (Mtb). Type 2 diabetes mellitus (T2DM) is one of the leading predisposing factors for development of TB after HIV/AIDS. Glibenclamide is a widely used anti-diabetic drug in low and middle-income countr...
Autores principales: | Kewcharoenwong, Chidchamai, Prabowo, Satria A., Bancroft, Gregory J., Fletcher, Helen A., Lertmemongkolchai, Ganjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157405/ https://www.ncbi.nlm.nih.gov/pubmed/30283449 http://dx.doi.org/10.3389/fimmu.2018.02109 |
Ejemplares similares
-
Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione
por: Kewcharoenwong, Chidchamai, et al.
Publicado: (2016) -
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection
por: Kewcharoenwong, Chidchamai, et al.
Publicado: (2013) -
Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes
por: Nithichanon, Arnone, et al.
Publicado: (2020) -
Increased abundance of ADAM9 transcripts in the blood is associated with tissue damage
por: Rinchai, Darawan, et al.
Publicado: (2016) -
Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei
por: Kessler, Bianca, et al.
Publicado: (2017)